Drreddys Laboratories | RDY - Pre Tax Profit


Drreddys Laboratories reported INR2B in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
ANI Pharmaceuticals USD 31.48M 18.04M Dec/2025
Aurora Cannabis CAD 11.41M 12.99M Mar/2026
Bayer EUR -3.37B 2.21B Dec/2025
Canopy Growth CAD -157.96M 95.71M Mar/2026
Cipla INR 7.49B 4.2B Mar/2026
Corcept Therapeutics USD 9.91M 5.33M Dec/2025
Drreddys Laboratories INR 2B 13.43B Mar/2026
GlaxoSmithKline GBP 2.14B 919M Mar/2026
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Lonza CHF 624M 197M Dec/2024
Novartis USD 3.84B 802M Mar/2026
Pacira USD 571K 8.95M Dec/2025
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Prestige Brands USD 61.81M 7.32M Dec/2025
Richter Gedeon HUF 78.56B 32.66B Dec/2024
Sun Pharmaceuticals INR 42.27B 595.5M Dec/2025
Supernus Pharmaceuticals USD -5.95M 4.04M Mar/2026
Teva Pharmaceutical Industries USD 753M 662M Mar/2026